Trifluridine-Tipiracil: clinical trials recruiting now
9
Recruiting trials
15
Conditions studied
28
US states with sites
14
Countries
Phase breakdown
Phase 1 4
Phase 2 6
Phase 3 1
Conditions being studied
Recruiting trials involving Trifluridine-Tipiracil
- 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
- A Study of ASP1002 in Adults for Treatment of Solid Tumors
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Second-line Treatment of Metastatic Colorectal Cancer
- Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
- Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy
- ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Common questions
How many recruiting trials involve Trifluridine-Tipiracil?
9 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.